Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Alcoholism, Clinical and Experimental Research|December 24, 2009
Revisiting intragastric ethanol intubation as a dependence induction method for studies of ethanol reward and motivation in ratsSimone Braconi, Nimish Sidhpura, Harinder Aujla, et al.
Nature Neuroscience|November 19, 2002
Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitizationEmanuela Izzo, Rémi Martin-Fardon, George F Koob, et al.
Biochemical Pharmacology|March 16, 2007
Modulation of GSH levels in ABCC1 expressing tumor cells triggers apoptosis through oxidative stressRémi-Martin Laberge, Joel Karwatsky, Maximilian C Lincoln, et al.
Scientific Reports|March 9, 2024
LY2444296, a κ-opioid receptor antagonist, selectively reduces alcohol drinking in male and female Wistar rats with a history of alcohol dependenceFrancisco J Flores-Ramirez, Jessica M Illenberger, Glenn Pascasio, et al.
Neuropharmacology|August 14, 2023
Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatementJessica M Illenberger, Francisco J Flores-Ramirez, Glenn Pascasio, et al.
Neuropharmacology|July 18, 2023
ADX106772, an mGlu2 receptor positive allosteric modulator, selectively attenuates oxycodone taking and seekingJessica M Illenberger, Francisco J Flores-Ramirez, Alessandra Matzeu, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 2017
Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in RatsGiordano de Guglielmo, Alessandra Matzeu, Jenni Kononoff, et al.
Frontiers in Pharmacology|May 14, 2023
Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female ratsJessica M Illenberger, Francisco J Flores-Ramirez, Alessandra Matzeu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 30, 2007
Subchronic cannabinoid agonist (WIN 55,212-2) treatment during cocaine abstinence alters subsequent cocaine seeking behaviorGustavo González-Cuevas, Harinder Aujla, Rémi Martin-Fardon, et al.
Pageof 8